VRTX · News · 20260819N
Revenue Performance and Mix
VERTEX PHARMACEUTICALS INC / MA · 2026-08-19 · Importance 29 · Surprise 22 · No source text
Vertex reported quarterly revenue of $3.33 billion, exceeding analyst estimates. Revenue increased 12.5% year over year in the latest quarterly earnings. The reported revenue growth exceeded the materiality threshold for year-over-year changes.
Key facts
- Vertex Pharmaceuticals showed a 12.5% year-over-year revenue increase in its latest quarterly earnings. source
- Vertex Pharmaceuticals reported quarterly revenue of $3.33 billion, exceeding expectations. source
- Vertex Pharmaceuticals reported quarterly revenue of $3.33 billion. source
- Vertex Pharmaceuticals reported adjusted earnings per share of $4.73 which narrowly missed consensus estimates. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +12.5% | Vertex Pharmaceuticals showed a 12.5% year-over-year revenue increase in its latest quarterly earnings. |